| Market revenue in 2023 | USD 47.7 million |
| Market revenue in 2030 | USD 70.6 million |
| Growth rate | 5.8% (CAGR from 2024 to 2030) |
| Largest segment | Detection of latent infection (skin test & igra) |
| Fastest growing segment | Detection of Drug Resistance (DST) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Nucleic Acid Testing, Detection of Latent Infection (Skin Test & IGRA), Detection of Drug Resistance (DST), Other Methods, Phage Assay, Cytokine Detection Assay, Diagnostic Laboratory Methods, Radiographic Method |
| Key market players worldwide | Abbott Laboratories, Becton Dickinson & Co, Roche Holding AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, Qiagen NV, Hologic Inc, BD, Hain Lifescience, Cepheid |
Publish Date: Mar 10, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Hain Lifescience | View profile | 51-100 | Nehren, Baden-Wurttemberg, Germany, Europe | www.hain-lifescience.de/ |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Tuberculosis Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Detection Of Latent Infection (Skin Test & Igra) was the largest segment with a revenue share of 41.3% in 2023.
Horizon Databook has segmented the Spain tuberculosis diagnostics market based on nucleic acid testing, detection of latent infection (skin test & igra), detection of drug resistance (dst), other methods, phage assay, cytokine detection assay, diagnostic laboratory methods, radiographic method covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain tuberculosis diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into Spain tuberculosis diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
